These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Bolhaar MG, Karstaedt AS. Clin Infect Dis; 2007 Jul 15; 45(2):254-60. PubMed ID: 17578788 [Abstract] [Full Text] [Related]
5. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa. Hernández Pérez E, Dawood H. J Int Assoc Physicians AIDS Care (Chic); 2010 Jul 15; 9(2):109-12. PubMed ID: 20484736 [Abstract] [Full Text] [Related]
6. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting. Manosuthi W, Prasithsirikul W, Chumpathat N, Suntisuklappon B, Athichathanabadi C, Chimsuntorn S, Sungkanuparph S. Int J Infect Dis; 2008 Nov 15; 12(6):582-6. PubMed ID: 18337140 [Abstract] [Full Text] [Related]
7. Asymptomatic hyperlactataemia: predictive value, natural history and correlates. McComsey GA, Yau L. Antivir Ther; 2004 Apr 15; 9(2):205-12. PubMed ID: 15134182 [Abstract] [Full Text] [Related]
12. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. Calza L, Manfredi R, Chiodo F. Clin Nutr; 2005 Feb 15; 24(1):5-15. PubMed ID: 15681097 [Abstract] [Full Text] [Related]
13. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Boubaker K, Flepp M, Sudre P, Furrer H, Haensel A, Hirschel B, Boggian K, Chave JP, Bernasconi E, Egger M, Opravil M, Rickenbach M, Francioli P, Telenti A. Clin Infect Dis; 2001 Dec 01; 33(11):1931-7. PubMed ID: 11692306 [Abstract] [Full Text] [Related]
14. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. Smith CJ, Olsen CH, Mocroft A, Viard JP, Staszewski S, Panos G, Staub T, Blaxhult A, Vetter N, Lundgren JD. AIDS; 2008 Jan 02; 22(1):47-56. PubMed ID: 18090391 [Abstract] [Full Text] [Related]
19. Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study. Schutz C, Boulle A, Stead D, Rebe K, Osler M, Meintjes G. AIDS Res Ther; 2010 May 26; 7():13. PubMed ID: 20500901 [Abstract] [Full Text] [Related]
20. Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis. Lonergan JT, Barber RE, Mathews WC. AIDS; 2003 Nov 21; 17(17):2495-9. PubMed ID: 14600521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]